(Q34054895)

30 July 2017

title

Substructure-based virtual screening for adenosine A2A receptor ligands (English)

1 reference

30 July 2017

1 reference

Adriaan P Ijzerman

5

0 references

Andreas Bender

series ordinal

4

object named as

Andreas Bender

1 reference

30 July 2017

Eelke van der Horst

1

1 reference

30 July 2017

Rianne van der Pijl

series ordinal

2

1 reference

30 July 2017

Thea Mulder-Krieger

series ordinal

3

1 reference

30 July 2017

publication date

21 October 2011

1 reference

30 July 2017

1 reference

30 July 2017

volume

6

1 reference

30 July 2017

issue

12

1 reference

30 July 2017

page(s)

2302-2311

1 reference

The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100369

Structural diversity of G protein-coupled receptors and significance for drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100369

How many drug targets are there?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100369

Crystal structure of rhodopsin: A G protein-coupled receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100369

High-resolution crystal structure of an engineered human beta2-adrenergic G protein-coupled receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100369

Structure of a beta1-adrenergic G-protein-coupled receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100369

The 2.6 angstrom crystal structure of a human A2A adenosine receptor bound to an antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100369

Structures of the CXCR4 chemokine GPCR with small-molecule and cyclic peptide antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100369

Structure of the Human Dopamine D3 Receptor in Complex with a D2/D3 Selective Antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100369

The in vitro pharmacology of ZM 241385, a potent, non‐xanthine, A2a selective adenosine receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100369

Suppression of inflammatory and immune responses by the A(2A) adenosine receptor: an introduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100369

Role of extracellular adenosine in acute lung injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100369

A2A adenosine receptor protects tumors from antitumor T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100369

The adenosinergic immunomodulatory drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100369

Adenosine, adenosine A 2A antagonists, and Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100369

A meta-analysis of coffee drinking, cigarette smoking, and the risk of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100369

Potential therapeutic interest of adenosine A2A receptors in psychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100369

Structure-based discovery of novel chemotypes for adenosine A(2A) receptor antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100369

Structure-based discovery of A2A adenosine receptor ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100369

Adenosine receptors as therapeutic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100369

Comparison of CGS 15943, ZM 241385 and SCH 58261 as antagonists at human adenosine receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100369

Design, synthesis, and biological evaluation of C9- and C2-substituted pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines as new A2A and A3 adenosine receptors antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100369

2-Amino-6-furan-2-yl-4-substituted nicotinonitriles as A2A adenosine receptor antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100369

A new generation of adenosine receptor antagonists: from di- to trisubstituted aminopyrimidines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100369

Crystal structure of the ligand-free G-protein-coupled receptor opsin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100369

Crystal structure of opsin in its G-protein-interacting conformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100369

Chemical Entities of Biological Interest: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100369

ZINC--a free database of commercially available compounds for virtual screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100369

Substructure mining using elaborate chemical representation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100369

Substructure mining of GPCR ligands reveals activity-class specific functional groups in an unbiased manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100369

2,6-disubstituted and 2,6,8-trisubstituted purines as adenosine receptor antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100369

2,6,8-trisubstituted 1-deazapurines as adenosine receptor antagonists.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100369

3D-pharmacophore models for selective A2A and A2B adenosine receptor antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100369

inferred from DOI database lookup

7 January 2021

based on heuristic

Why are A(2B) receptors low-affinity adenosine receptors? Mutation of Asn273 to Tyr increases affinity of human A(2B) receptor for 2-(1-Hexynyl)adenosine.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100369

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1002/CMDC.201100369

1 reference

30 July 2017

1 reference